{"id":52865,"date":"2023-01-12T17:02:17","date_gmt":"2023-01-12T16:02:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cell-line-and-membrane-global-market-report-2022-increases-in-vaccine-production-boosts-growth-researchandmarkets-com\/"},"modified":"2023-01-12T17:02:17","modified_gmt":"2023-01-12T16:02:17","slug":"cell-line-and-membrane-global-market-report-2022-increases-in-vaccine-production-boosts-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cell-line-and-membrane-global-market-report-2022-increases-in-vaccine-production-boosts-growth-researchandmarkets-com\/","title":{"rendered":"Cell Line and Membrane Global Market Report 2022: Increases in Vaccine Production Boosts Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Cell Line and Membrane Market By Products, By Source, By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global cell line and membrane market was valued at $4,533.04 million in 2021, and is projected to reach $10,574.56 million by 2031, registering a CAGR of 8.8% from 2022 to 2031.\n<\/p>\n

\nA cell line is a permanently established cell culture that will multiply indefinitely in a given appropriate fresh medium and space and is frequently used to investigate biological processes in place of primary cells. Transfection, selection, and single-cell cloning are all a part of the cell line generation process.\n<\/p>\n

\nVarious types of cells are used to create different cell lines. Cell lines allow for the gradual changes in cell structure, physiology, and genetic makeup in a controlled setting.. Cell lines are derived from single cells and are used to make fusion proteins, monoclonal antibodies, and vaccines.\n<\/p>\n

\nCell lines have revolutionized scientific research and they are widely used in the production of vaccines, testing drug metabolisms & cytotoxicity, antibody production, study of gene function, generation of artificial tissues (artificial skin), and synthesis of biological compounds (therapeutic proteins).\n<\/p>\n

\nThe key factors that drive the growth of market are rise in the prevalence of cancer & chronic diseases, rise in geriatric population, and an increase in vaccine production. In addition, the rise in novel drug development activities, growth in use of mammalian cell for cell line production, and surge in technological advancements in expression vector design are the key factors that boost the market growth. For instance, according to the International Agency of Cancer Research, 9,503,710 new cancer cases were diagnosed in Asia in 2020.\n<\/p>\n

\nHowever, the strict regulatory framework coupled with the time-consuming process for the development of stable lines hampers the market growth. Conversely, emerging healthcare market in developing countries & low-income countries and increase in the risk of pandemic & communicable diseases are expected to provide lucrative opportunity for the growth of market during the forecast period.\n<\/p>\n

\nNorth America accounted for a majority of the cell line and membrane market share in 2021 and is anticipated to remain dominant during the forecast period owing to rise in the prevalence of cancer, increased use of media & reagents for cell line development, and presence of major key players in the region.\n<\/p>\n

\nAsia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rise in prevalence of chronic diseases and increase in geriatric population in developing countries.\n<\/p>\n

\nThe key players that operate in the cell line and membrane market are Advanced Instruments LLC, AGC Biologics, Cytiva Lifesciences, Sartorius Cellgenix Gmbh, Premas Biotech, Selexis SA, Lonza, Samsung Biologics, PromoCell, Thermofisher Scientific Inc, Imegenex India Pvt. Ltd., and ProBioGen.\n<\/p>\n

\nKey Benefits For Stakeholders<\/strong>\n<\/p>\n